Who founded ImmusanT?

ImmusanT was founded by Leslie Williams in 2010.

Who are ImmusanT's investors?

ImmusanT's investors include Vatera Healthcare Partners.

How much funding has ImmusanT raised?

ImmusanT has disclosed $32.7M raised across 2 rounds.

Where is ImmusanT headquartered?

ImmusanT is headquartered in Cambridge, US.

ImmusanT

Cambridge, US · Founded 2010 · Delaware corporation · 1 known investors

immusant.com ↗

ImmusanT works on scientific research into the mechanisms of celiac disease, collaborating with investigators from academic and medical research institutions. The company operates in the biotechnology and immunology field focused on this autoimmune condition.

BiotechHealthtech

Founders & leadership

ImmusanT was founded in 2010 by Leslie Williams.

Leslie WilliamsFounder

Thomas DanielNamed on SEC filing

Steven GillisNamed on SEC filing

Thomas KoestlerNamed on SEC filing

Craig EstwickNamed on SEC filing

Justin SunNamed on SEC filing

Sundar KodiyalamNamed on SEC filing

Board

Ceclia GonzaloBoard director

Kevin FerroBoard director

Investors · 1

Vatera Healthcare Partners✓ verified

Reported raises · per SEC filings

Form D private placements

$32.7M disclosed across 2 rounds · 2014–2017

▶$19.9MraisedNov 2017 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Thomas DanielDirector
Leslie WilliamsExecutive Officer, Director
Ceclia GonzaloDirector
Kevin FerroDirector
Steven GillisDirector
Thomas KoestlerDirector

Offering amount: $39.9M
Amount sold: $19.9M
First sale: Nov 2017
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$12.8MraisedDec 2014 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Craig EstwickDirector
Thomas KoestlerDirector
Justin SunDirector
Sundar KodiyalamDirector
Kevin FerroDirector
Leslie WilliamsExecutive Officer, Director

Offering amount: $12.8M
Amount sold: $12.8M
First sale: Dec 2014
Incorporated: Corporation, Delaware, 2010
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Immunovant3 shared keywordsImmunovant is a clinical-stage biopharmaceutical company developing treatments for people with autoimmune diseases, with a focus on therapies targeting the FcRn receptor. It advances a pipeline of candidates across multiple therapeutic areas through clinical trials.

Companies competing with ImmusanT for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does ImmusanT do?: ImmusanT works on scientific research into the mechanisms of celiac disease, collaborating with investigators from academic and medical research institutions. The company operates in the biotechnology and immunology field focused on this autoimmune condition.
Who founded ImmusanT?: ImmusanT was founded by Leslie Williams in 2010.
Who are ImmusanT's investors?: ImmusanT's investors include Vatera Healthcare Partners.
How much funding has ImmusanT raised?: ImmusanT has disclosed $32.7M raised across 2 rounds.
Where is ImmusanT headquartered?: ImmusanT is headquartered in Cambridge, US.